Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sedentary Behavior 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Liver Neoplasms 1Invasive Breast Carcinoma 1High-Frequency Microsatellite Instability 1Head and Neck Carcinoma 1Fatigue 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma × Monitoring, Physiologic × Clear all
NCT03574012 2024-01-23

SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

Fred Hutchinson Cancer Center

Phase NA Completed
41 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡